- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vidar drops plans for laser digitizer
Vidar drops plans for laser digitizerX-ray film digitizer vendor Vidar Systems has decided not to proceed with commercialization of VXR-LS, a laser film digitizer the company discussed at the 1997 meeting of the Radiological Society of North
Vidar drops plans for laser digitizer
X-ray film digitizer vendor Vidar Systems has decided not to proceed with commercialization of VXR-LS, a laser film digitizer the company discussed at the 1997 meeting of the Radiological Society of North America meeting (
PNN
1/98). Although the Herndon, VA-based company received Food and Drug Administration 510(k) clearance in April for VXR-LS, Vidar decided not to go ahead with the product because of the high maintenance required by laser digitizers and the rapidly growing performance of CCD-based digitizers.
In other Vidar news, the company has released Photoshop plug-in 2.0, which allows radiographers to operate the firm's VXR line of x-ray film digitizers from a Macintosh computer. In addition, the new release adds support for the company's Film Director option, a multi-film feeder that allows digitization of up to 10 films at a touch of a button (PNN 1/98).
- Search again
- Homepage
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
